Hill-Rom Accused of Wrongfully Pulling Plug on Bardy Deal
Mar 01 2021, 9:28 PM
March 01 2021, 9:02 PM
March 01 2021, 9:28 PM
(Bloomberg) Hospital-bed maker Hill-Rom Holdings Inc. is accused of wrongfully pulling the plug on a $375 million buyout of startup Bardy Diagnostics over changes to government reimbursement rates for its cardiac-monitoring system.Officials of Seattle-based Bardy asked a Delaware judge to force Batesville, Indiana-based Hill-Rom to complete the acquisition, saying the proposed Medicare-payment revisions donât provide a proper lega.
(Bloomberg) Hospital-bed maker Hill-Rom Holdings Inc. is accused of wrongfully pulling the plug on a $375 million buyout of startup Bardy Diagnostics over changes to government reimbursement rates for its cardiac-monitoring system.
Hillrom Provides Update on Planned Acquisition of Bardy Diagnostics, Inc prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Hillrom to Present at the Barclays Global Healthcare Conference
News provided by
Share this article
Share this article
CHICAGO, Feb. 25, 2021 /PRNewswire/ Hillrom (NYSE: HRC) today announced that it will present at the Barclays Global Healthcare Conference on Wednesday, March 11, 2021. John Groetelaars, Hillrom s president and chief executive officer, will participate in a fireside chat at 9:45 a.m. Eastern Time via webcast and will host virtual one-on-one meetings immediately following.
The live webcast of Hillrom s presentation can be found at www.hillrom.com. A recorded replay will be available after the conclusion of the live event for a period of 90 days.
/PRNewswire/ Hillrom (NYSE: HRC) previously announced its intention to acquire Bardy Diagnostics, Inc. (BardyDx), an innovator in digital health and a.
Hillrom is transforming care with highly differentiated sensing and digital communication capabilities that drive improved patient safety and ensure timely, effective clinical intervention, said Hillrom President and CEO John Groetelaars. We look forward to bringing these critical technologies to more customers around the world as we deliver on our vision of Advancing Connected Care™.
Hillrom will provide EarlySense a license to the technology, as EarlySense continues to develop next-generation AI-based sensing technologies specifically for the remote patient care market. EarlySense technology has monitored over one million patients and helped care teams save tens of thousands of lives. Transferring this technology to Hillrom will advance our global impact in acute care settings, said Matt Johnson, CEO of EarlySense. Simultaneously, we are excited to focus our future on post-acute remote patient care, which is growing dramatically and has experienced widespread acceptance